The specter of a two-tier healthcare system is materializing in England as a growing number of patients turn to private providers to escape crushing NHS waiting lists, according to a damning new report from Healthwatch England. A national survey of nearly 2,600 adults revealed that 16% had paid out-of-pocket for private medical tests, treatments, or consultations in the past 12 months—a sharp increase from just 9% in 2022. The watchdog’s findings, based on polling data and an analysis of 390,000 public feedback submissions over three years, underscore a systemic crisis in public healthcare where wealth increasingly dictates access. Nearly four in 10 patients now wait longer than the NHS’s 18-week target for hospital treatment, pushing many to seek faster—but costly—alternatives.
Why Patients Are Opting for Private Care: The NHS Wait Crisis
The exodus to private healthcare is not merely about convenience—it is a symptom of a National Health Service stretched to its breaking point. Healthwatch England’s data shows that 40% of those who paid for private care cited long NHS waits as their primary motivation. The situation has deteriorated to the point where nearly four in 10 patients now breach the NHS’s 18-week target for elective hospital treatment, a threshold that has become increasingly difficult to meet.
The Six-Week Scan Gap: How Private Providers Exploit Delays
One of the starkest disparities lies in diagnostic services. While the NHS aims to complete scans and tests within six weeks, private providers can often schedule them within 48 hours. This gap has created a lucrative side market where patients—both wealthy and middle-class—pay privately for MRI scans, blood tests, or endoscopies, then return to the NHS with their results to fast-track their treatment. According to the Private Healthcare Information Network (PHIN), nearly 950,000 operations and treatments were performed in the private sector across the UK in 2023 alone. An estimated one million additional diagnostic tests are conducted privately each year, often as a workaround to NHS bottlenecks.
Mental Health and Weight-Loss Drugs: The New Frontiers of Private Care
The private healthcare surge extends beyond physical treatments. Healthwatch England reported a marked increase in patients paying for mental health services, including therapy and counseling, as NHS mental health waiting lists balloon. Additionally, the watchdog noted a rise in individuals funding weight-loss medications like semaglutide (commonly known as Ozempic), which are rarely available on the NHS for cosmetic weight loss. These trends reflect a broader shift where patients—facing years-long waits for basic care—are increasingly willing to self-fund treatments once considered luxuries.
The Wealth Divide: Who Can Afford to Go Private?
Access to private healthcare remains heavily stratified by income. The Healthwatch England poll found that 35% of households earning over £80,000 annually had used private healthcare in the past year, compared to just 10% of those earning under £20,000. This disparity underscores a troubling trend: the NHS, originally designed as a universal service, is evolving into a system where the affluent can buy their way to faster care while lower-income patients bear the brunt of delays. Chloe Leckie, a 51-year-old woman from Buckinghamshire, embodies this divide. After years of battling endometriosis—a condition marked by chronic pain and inflammation—she was repeatedly told by the NHS to try physiotherapy and painkillers, despite her deteriorating condition.
‘I was in tremendous pain, but just could not get the help I needed from the NHS,’ Leckie said. ‘I was lucky really that the policy change meant I could go private—I know not everybody has that opportunity.’
Leckie’s story took a turn when her husband’s workplace health insurance policy expanded to cover her treatment. At £20,000, the cost of a hysterectomy—along with an appendectomy—was prohibitive for most, but her new coverage made it possible. Today, she continues to pay privately for physiotherapy to manage her symptoms. Her case highlights how even those with insurance face financial strain, as many policies cover only a fraction of the total cost of complex procedures.
The Two-Tier System in Action: How Private Care Complements (and Undermines) the NHS
The rise of private healthcare is not happening in isolation; it is increasingly intertwined with the NHS itself. David Hare, CEO of the Independent Healthcare Providers Network (IHPN), described this trend as the “new normal,” noting that many patients use private services for diagnostics or initial consultations before returning to the NHS for follow-up care. This hybrid approach, while alleviating some pressure on the public system, also risks deepening inequalities. Patients who can afford private scans or specialist appointments gain a competitive edge in accessing NHS treatments, while those without means are left waiting.
The GP Burden: How Private Care Shifts Responsibility—and Workload—to Family Doctors
General practitioners are caught in the crossfire of this evolving landscape. Dr. Katie Bramall, chair of the British Medical Association’s GP Committee, reported a sharp rise in patients using private care and then returning to NHS GPs for ongoing management. These doctors must then review private test results, re-assess diagnoses, and determine whether patients qualify for NHS-funded treatment—adding layers of administrative work to already overstretched practices. ‘We believe urgent, nationally-funded action is needed to bring waiting lists down and to ensure all patients can access high-quality care quickly, whether it’s in the NHS or privately,’ Bramall stated.
Government Response: Promises of Reform Amid Persistent Delays
The Department of Health and Social Care has acknowledged the crisis, pointing to recent improvements such as the lowest waiting list levels in nearly three years. A spokeswoman stated that the government is ‘determined to reduce the delays that meant some felt the need to pay for care’ and aims to eliminate the ‘unacceptable two-tier healthcare system’ inherited from previous administrations. ‘Our extra investment and modernisation is beginning to turn the tide, but we know there’s a long way to go,’ she added. Yet critics argue that incremental progress is insufficient given the scale of the problem. NHS England’s own data shows that as of early 2024, 7.6 million patients were waiting for elective care—a record high.
Historical Context: How Did the NHS Reach This Breaking Point?
The NHS, founded in 1948 as a beacon of egalitarian healthcare, has long been straining under the weight of demographic shifts, chronic underfunding, and post-pandemic backlogs. The COVID-19 pandemic exacerbated existing issues, with millions of non-emergency procedures postponed to prioritize pandemic response. Even before the pandemic, however, waiting times had been creeping upward due to austerity-era funding cuts and staffing shortages. The current crisis reflects decades of policy decisions that prioritized short-term cost savings over sustainable investment in infrastructure and workforce. Now, as private healthcare fills the gaps, the NHS risks becoming a residual service for those who cannot afford alternatives.
Key Takeaways: What the Healthwatch England Report Reveals
- 16% of English patients used private healthcare in 2023–24 to bypass NHS waits, up from 9% in 2021–22—a 78% increase.
- Nearly 40% of patients now wait longer than the NHS’s 18-week target for hospital treatment, fueling the private sector’s growth.
- Wealth disparities in access are stark: 35% of high-income households (£80k+) use private care vs. 10% of low-income households (under £20k).
- Private providers offer diagnostics in as little as 48 hours, compared to the NHS’s six-week target, creating a two-tier system.
- The trend is accelerating, with 950,000 private operations in 2023 and over 1 million private diagnostic tests annually.
The Human Cost: Stories from the Frontlines of the NHS Crisis
Behind the statistics are real people whose lives have been upended by the NHS’s failures. Take the case of Mark Thompson, a 42-year-old teacher from Manchester, who waited 14 months for an MRI scan to diagnose persistent back pain. After his NHS appointment was delayed three times, he paid £450 for a private scan, which revealed a herniated disc. ‘I couldn’t walk without screaming,’ Thompson said. ‘But the NHS told me my condition wasn’t ‘urgent enough.’ Now, he’s considering private surgery to avoid the NHS waiting list for spinal specialists. Stories like his are becoming commonplace, illustrating how the system’s dysfunction is reshaping lives.
What’s Next? Policy Solutions and the Path Forward
Health experts and patient advocates are calling for a multi-pronged approach to address the crisis. Dr. Bramall of the BMA emphasizes the need for ‘urgent, nationally-funded action’ to reduce waiting lists, including increasing staffing, expanding diagnostic capacity, and investing in primary care. Hare of the IHPN suggests greater collaboration between public and private sectors to ‘integrate private capacity into NHS pathways’ where it can alleviate pressure without exacerbating inequalities. Meanwhile, Healthwatch England urges the NHS to improve communication with patients, providing clearer timelines and symptom management advice to reduce anxiety during waits.
Frequently Asked Questions
Frequently Asked Questions
- How many people in England are using private healthcare due to NHS waits?
- A 2024 Healthwatch England survey found that 16% of English adults—nearly 1 in 6—paid for private healthcare in the past year to avoid NHS delays, up from 9% in 2022.
- What are the main reasons people choose private care over the NHS?
- The primary driver is long NHS waiting times, with 40% of private healthcare users citing delays as their reason. Other factors include faster access to diagnostics (e.g., scans in 48 hours vs. NHS’s six-week target) and perceived higher quality of care in some private facilities.
- Is the government taking steps to reduce NHS waiting times?
- The Department of Health says waiting lists are at their lowest in nearly three years due to increased investment and modernization efforts. However, critics argue progress is too slow, with 7.6 million patients still awaiting elective care as of early 2024.
